Cancers of the Pelvic Organs: Contemporary Management and Actions for Improving Patients’ Quality of Life: 2nd Edition

Dear Colleagues,

I am pleased to invite you to the second edition of our Special Issue, published in 2023, entitled “Cancers of the Pelvic Organs: Contemporary Management and Actions for Improving Patients’ Quality of Life”. In the first edition, we published eight articles, both original and reviews, focused on issues such as the treatment of ovarian, endometrial, bladder and prostate cancer. On the one hand, the articles concerned surgical treatment including robotic treatment and chemotherapy. On the other hand, they discussed the possibility of physiotherapeutic support for patients. The work also included an analysis of complications resulting from the treatment used.

Bearing in mind that neoplasms affect a large population of women and men worldwide each year, it is important to search for new, advanced diagnostic and therapeutic techniques that would allow for early cancer diagnosis, satisfactory treatment results, and improvements in patients’ quality of life.

The second edition of our Special Issue aims to further explore and present the latest achievements and analyses in the field of managing neoplastic diseases of the pelvic organs both in women and men, i.e., the lower urogenital system and the lower gastrointestinal tract. In particular, we invite professionals dealing with the issues of modern methods in oncological diagnosis and treatment, with special emphasis on the problem of treatment complications, methods of their prevention, oncofertility, assessment of patients’ quality of life, supportive therapies, new technologies affecting the quality of life, life expectancy, and overall survival, as well as physiotherapeutic and psychological support in oncological treatment. For that reason, we extend our invitation to a broad, multidisciplinary team consisting of oncologists, gynecologic oncologists, oncologic urologists, urogynecologists, urologists, physiotherapists, psychologists, radiotherapists, clinical oncologists, and surgeons. You are welcome to submit/We are interested in publishing original research papers, reviews, systematic reviews, and meta-analyses.

We hope that our Special Issue will become a platform for the exchange of experiences in the field of evidence-based medicine for better treatment of oncological diseases of the pelvic area. Thus, hopefully, we will be able to improve the quality of patients’ lives together.

We look forward to receiving your contributions.

Dr. Agnieszka Mazur-Bialy
Dr. Marcin Opławski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gynecological cancers, e.g., endometrial, cervical, ovarian, and vulvar cancer
• urogenital tract cancers in men, e.g., bladder, prostate, penis, and testicular cancer
• gastrointestinal cancers
• complications of oncological treatment, e.g., pelvic floor disfunction: incontinence and POP
• patients’ quality of life and possibilities of its improvement
• oncofertility
• physiotherapy
• oncology treatment (modern surgical approach, including robotics, chemotherapy, radiotherapy, immunotherapy, targeted therapy)
• biological basis of pathogenesis and cancer progression, biological markers, anticancer agents
• cancer prophylaxis and prevention—current trends and opportunities

• Cancers of the Pelvic Organs: Contemporary Management and Actions for Improving Patients’ Quality of Life in Journal of Clinical Medicine (8 articles)